355 related articles for article (PubMed ID: 24706040)
1. Exacerbation-like respiratory symptoms in individuals without chronic obstructive pulmonary disease: results from a population-based study.
Tan WC; Bourbeau J; Hernandez P; Chapman KR; Cowie R; FitzGerald JM; Marciniuk DD; Maltais F; Buist AS; O'Donnell DE; Sin DD; Aaron SD;
Thorax; 2014 Aug; 69(8):709-17. PubMed ID: 24706040
[TBL] [Abstract][Full Text] [Related]
2. Exacerbations and health care resource utilization in patients with airflow limitation diseases attending a primary care setting: the PUMA study.
Montes de Oca M; Aguirre C; Lopez Varela MV; Laucho-Contreras ME; Casas A; Surmont F
Int J Chron Obstruct Pulmon Dis; 2016; 11():3059-3067. PubMed ID: 27994446
[TBL] [Abstract][Full Text] [Related]
3. Frequency of self-reported COPD exacerbation and airflow obstruction in five Latin American cities: the Proyecto Latinoamericano de Investigacion en Obstruccion Pulmonar (PLATINO) study.
Montes de Oca M; Tálamo C; Halbert RJ; Perez-Padilla R; Lopez MV; Muiño A; Jardim JRB; Valdivia G; Pertuzé J; Moreno D; Menezes AMB
Chest; 2009 Jul; 136(1):71-78. PubMed ID: 19349388
[TBL] [Abstract][Full Text] [Related]
4. Respiratory Symptoms Items from the COPD Assessment Test Identify Ever-Smokers with Preserved Lung Function at Higher Risk for Poor Respiratory Outcomes. An Analysis of the Subpopulations and Intermediate Outcome Measures in COPD Study Cohort.
Martinez CH; Murray S; Barr RG; Bleecker E; Bowler RP; Christenson SA; Comellas AP; Cooper CB; Couper D; Criner GJ; Curtis JL; Dransfield MT; Hansel NN; Hoffman EA; Kanner RE; Kleerup E; Krishnan JA; Lazarus SC; Leidy NK; O'Neal W; Martinez FJ; Paine R; Rennard SI; Tashkin DP; Woodruff PG; Han MK;
Ann Am Thorac Soc; 2017 May; 14(5):636-642. PubMed ID: 28459622
[TBL] [Abstract][Full Text] [Related]
5. The objective evaluation of obstructive pulmonary diseases with spirometry.
Ozkaya S; Dirican A; Tuna T
Int J Chron Obstruct Pulmon Dis; 2016; 11():2009-15. PubMed ID: 27616884
[TBL] [Abstract][Full Text] [Related]
6. Characteristics of COPD in never-smokers and ever-smokers in the general population: results from the CanCOLD study.
Tan WC; Sin DD; Bourbeau J; Hernandez P; Chapman KR; Cowie R; FitzGerald JM; Marciniuk DD; Maltais F; Buist AS; Road J; Hogg JC; Kirby M; Coxson H; Hague C; Leipsic J; O'Donnell DE; Aaron SD;
Thorax; 2015 Sep; 70(9):822-9. PubMed ID: 26048404
[TBL] [Abstract][Full Text] [Related]
7. [Study of the clinical phenotype of symptomatic chronic airways disease by hierarchical cluster analysis and two-step cluster analyses].
Ning P; Guo YF; Sun TY; Zhang HS; Chai D; Li XM
Zhonghua Nei Ke Za Zhi; 2016 Sep; 55(9):679-83. PubMed ID: 27586974
[TBL] [Abstract][Full Text] [Related]
8. Impact of active and passive smoking as risk factors for asthma and COPD in women presenting to primary care in Syria: first report by the WHO-GARD survey group.
Mohammad Y; Shaaban R; Al-Zahab BA; Khaltaev N; Bousquet J; Dubaybo B
Int J Chron Obstruct Pulmon Dis; 2013; 8():473-82. PubMed ID: 24124359
[TBL] [Abstract][Full Text] [Related]
9. Identification of Asthma-COPD Overlap, Asthma, and Chronic Obstructive Pulmonary Disease Phenotypes in Patients with Airway Obstruction: Influence on Treatment Approach.
Romem A; Rokach A; Bohadana A; Babai P; Arish N; Azulai H; Glazer M; Izbicki G
Respiration; 2020; 99(1):35-42. PubMed ID: 31694032
[TBL] [Abstract][Full Text] [Related]
10. Frequency of exacerbations in patients with chronic obstructive pulmonary disease: an analysis of the SPIROMICS cohort.
Han MK; Quibrera PM; Carretta EE; Barr RG; Bleecker ER; Bowler RP; Cooper CB; Comellas A; Couper DJ; Curtis JL; Criner G; Dransfield MT; Hansel NN; Hoffman EA; Kanner RE; Krishnan JA; Martinez CH; Pirozzi CB; O'Neal WK; Rennard S; Tashkin DP; Wedzicha JA; Woodruff P; Paine R; Martinez FJ;
Lancet Respir Med; 2017 Aug; 5(8):619-626. PubMed ID: 28668356
[TBL] [Abstract][Full Text] [Related]
11. Outcomes for symptomatic non-obstructed individuals and individuals with mild (GOLD stage 1) COPD in a population based cohort.
Perez-Padilla R; Wehrmeister FC; de Oca MM; Lopez MV; Jardim JR; Muiño A; Valdivia G; Menezes AMB
Int J Chron Obstruct Pulmon Dis; 2018; 13():3549-3561. PubMed ID: 30464437
[TBL] [Abstract][Full Text] [Related]
12. Exacerbation-related impairment of quality of life and work productivity in severe and very severe chronic obstructive pulmonary disease.
Solem CT; Sun SX; Sudharshan L; Macahilig C; Katyal M; Gao X
Int J Chron Obstruct Pulmon Dis; 2013; 8():641-52. PubMed ID: 24376348
[TBL] [Abstract][Full Text] [Related]
13. Increased risk of exacerbation and hospitalization in subjects with an overlap phenotype: COPD-asthma.
Menezes AMB; Montes de Oca M; Pérez-Padilla R; Nadeau G; Wehrmeister FC; Lopez-Varela MV; Muiño A; Jardim JRB; Valdivia G; Tálamo C;
Chest; 2014 Feb; 145(2):297-304. PubMed ID: 24114498
[TBL] [Abstract][Full Text] [Related]
14. Changes in prevalence of chronic obstructive pulmonary disease and asthma in the US population and associated risk factors.
Halldin CN; Doney BC; Hnizdo E
Chron Respir Dis; 2015 Feb; 12(1):47-60. PubMed ID: 25540134
[TBL] [Abstract][Full Text] [Related]
15. Clinical relevance of fixed ratio vs lower limit of normal of FEV1/FVC in COPD: patient-reported outcomes from the CanCOLD cohort.
van Dijk W; Tan W; Li P; Guo B; Li S; Benedetti A; Bourbeau J;
Ann Fam Med; 2015; 13(1):41-8. PubMed ID: 25583891
[TBL] [Abstract][Full Text] [Related]
16. Predictors of exacerbations of asthma and COPD during one year in primary care.
Al-ani S; Spigt M; Hofset P; Melbye H
Fam Pract; 2013 Dec; 30(6):621-8. PubMed ID: 24115012
[TBL] [Abstract][Full Text] [Related]
17. Chronic obstructive pulmonary disease - diagnosis and management of stable disease; a personalized approach to care, using the treatable traits concept based on clinical phenotypes. Position paper of the Czech Pneumological and Phthisiological Society.
Zatloukal J; Brat K; Neumannova K; Volakova E; Hejduk K; Kocova E; Kudela O; Kopecky M; Plutinsky M; Koblizek V
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2020 Dec; 164(4):325-356. PubMed ID: 33325455
[TBL] [Abstract][Full Text] [Related]
18. Undiagnosed Chronic Obstructive Pulmonary Disease Contributes to the Burden of Health Care Use. Data from the CanCOLD Study.
Labonté LE; Tan WC; Li PZ; Mancino P; Aaron SD; Benedetti A; Chapman KR; Cowie R; FitzGerald JM; Hernandez P; Maltais F; Marciniuk DD; O'Donnell D; Sin D; Bourbeau J; ;
Am J Respir Crit Care Med; 2016 Aug; 194(3):285-98. PubMed ID: 26836958
[TBL] [Abstract][Full Text] [Related]
19. Identification and distribution of COPD phenotypes in clinical practice according to Spanish COPD Guidelines: the FENEPOC study.
Calle Rubio M; Casamor R; Miravitlles M
Int J Chron Obstruct Pulmon Dis; 2017; 12():2373-2383. PubMed ID: 28848338
[TBL] [Abstract][Full Text] [Related]
20. Asthma-COPD overlap syndrome (ACOS) in primary care of four Latin America countries: the PUMA study.
Montes de Oca M; Victorina Lopez Varela M; Laucho-Contreras ME; Casas A; Schiavi E; Mora JC
BMC Pulm Med; 2017 Apr; 17(1):69. PubMed ID: 28431499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
